Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05877976 · ClinicalTrials.gov registry record · NA

Impact of Visual Arts Immersion

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
41
Enrollment target

NCT05877976: Completed NA study, sponsored by NYU Langone Health.

NCT05877976 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05877976, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
41 participants
Enrollment target

Study Summary

The purpose of this study is to enhance engagement, coping and self-reflection by attuning nurses to creative and observational skills drawn from a visual arts pedagogical framework. To fulfill this goal, the investigators will cultivate an existing relationship between NYU Langone Health (NYULH) Nursing, the NYU Health Sciences Library, and museum educators at The Met to design and deliver an intervention of museum educator-led workshops that introduce nurses to arts appreciation skills to improve their practice and overall wellbeing. Participants will be asked to complete two surveys, pre- and post-intervention, Cultural Awareness Scale (CAS), which measures cultural awareness, sensitivity, knowledge and skills, and the Interpersonal Reactivity Index (IRI), which measures four separate aspects of empathy and its relationships with measures of social functioning, self-esteem, emotionality, and sensitivity to others. We will also solicit qualitative feedback via REDCap survey at the end of the intervention to gain insight into nurse's experiences of the art immersion program.

Primary Outcome

36-item questionnaire assessing cultural awareness, sensitivity, knowledge and skills. Each item is rated on a 7-point scale (ranging from "strongly disagree" to "strongly agree"). The total score ranges from 0-252. Lower scores indicate less cultural awareness, and higher scores indicate greater awareness.

Interventions

  • BEHAVIORAL Visual Arts Immersion

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2023-06-15
Est. Completion 2024-03-21
Phase NA
NYU Langone Health

1,164 total trials

What the finished NCT05877976 record still lists

NCT05877976 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Visual Arts Immersion is the first listed.

NCT05877976 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05877976 about?

NCT05877976 is a clinical study titled "Impact of Visual Arts Immersion". The purpose of this study is to enhance engagement, coping and self-reflection by attuning nurses to creative and observational skills drawn from a visual arts pedagogical framework. To fulfill this goal, the investigators will cultivate an existing relationship between NYU Langone Health (NYULH) Nu...

What is the current status of trial NCT05877976?

This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2023-06-15. Estimated completion is 2024-03-21.

What interventions are being tested in trial NCT05877976?

The interventions under investigation include: Visual Arts Immersion (BEHAVIORAL).

Who is sponsoring clinical trial NCT05877976?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05877976's enrollment target sits among peer trials

41 1446th of 2000 higher than 554 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03449238 · 41 participants · Phase 1

    Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients

  • NCT03900793 · 41 participants · Phase 1

    Losartan + Sunitinib in Treatment of Osteosarcoma

  • NCT04082520 · 41 participants · Phase 2

    Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

  • NCT04220190 · 41 participants · Phase 2

    RAPA-501 Therapy for ALS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05877976, the US trial registry maintained by the National Library of Medicine. NCT05877976 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.